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Abstract
Background: Cats appear to be the primary reservoir host for Bartonella koehlerae, an alpha Proteobacteria that is
most likely transmitted among cat populations by fleas (Ctenocephalides felis). Bartonella koehlerae has caused
endocarditis in a dog and in one human patient from Israel, but other clinically relevant reports involving this
bacterium are lacking. Despite publication of numerous, worldwide epidemiological studies designed to determine
the prevalence of Bartonella spp. bacteremia in cats, B. koehlerae has never been isolated using conventional blood
agar plates. To date, successful isolation of B. koehlerae from cats and from the one human endocarditis patient has
consistently required the use of chocolate agar plates.
Results: In this study, Bartonella koehlerae bacteremia was documented in eight immunocompetent patients by
PCR amplification and DNA sequencing, either prior to or after enrichment blood culture using Bartonella alpha
Proteobacteria growth medium. Presenting symptoms most often included fatigue, insomnia, joint pain, headache,
memory loss, and muscle pain. Four patients were also infected with Bartonella vinsonii subsp. berkhoffii genotype
II. After molecular documentation of B. koehlerae infection in these patients, a serological test was developed and
serum samples were tested retrospectively. Bartonella koehlerae antibodies were not detected (titers < 1:16) in 30
healthy human control sera, whereas five of eight patient samples had B. koehlerae antibody titers of 1:64 or
greater.
Conclusions: Although biased by a study population consisting of individuals with extensive arthropod and animal
exposure, the results of this study suggest that B. koehlerae bacteremia is more common in immunocompetent
people than has been previously suspected. Future studies should more thoroughly define modes of transmission
and risk factors for acquiring infection with B. koehlerae. In addition, studies are needed to determine if B. koehlerae
is a cause or cofactor in the development of arthritis, peripheral neuropathies or tachyarrhythmias in patients.
Background
Bartonella koehlerae has a relative short microbiological
history. In 1994, during a study designed to investigate
the prevalence of Bartonella henselae bacteremia in
domestic cats, B. koehlerae was isolated for the first
time from the blood of two flea-infested healthy cats
located on a farm in northern California [1,2]. Following
experimental subcutaneous inoculation of one of these
California B. koehlerae isolates, four cats became bac-
teremic for a mean of 74 days and each cat developed a
species-specific antibody response to B. koehlerae outer
membrane proteins [3]. Subsequently, B. koehlerae DNA
was amplified from cat fleas (Ctenocephalides felis) col-
lected from pets located throughout France [4]. Eighty-
one of 309 fleas tested by polymerase chain reaction
(PCR) and DNA sequencing contained a Bartonella
spp.; B. clarridgeiae was found in 68%, B. quintana in
17%, B. henselae in 11%, and B. koehlerae in 4%. Barto-
nella koehlerae DNA was also amplified from an uni-
dentified flea species removed from gerbils (Meriones
lybicus) in Afghanistan [5]. Bartonella koehlerae was
next isolated from a kitten in France suspected of hav-
ing caused cat scratch disease in the owner [6]. Based
upon these observations, cats are likely a primary reser-
voir host for B. koehlerae, as has been documented for
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B. henselae and B. clarridgeiae, with transmission among
cats most likely occurring by infestations of Ctenocepha-
lides felis; however, neither reservoir potential nor the
mode of transmission have been definitively confirmed.
To date, B. koehlerae has only been reported as a
human pathogen in a single patient from Israel, who
was diagnosed with culture-negative aortic valve endo-
carditis [7]. Those investigators subsequently isolated B.
koehlerae from stray cats in Israel, which were the pre-
sumed source of infection for their patient. In 2010, B.
koehlerae endocarditis was reported in a dog from Israel
[8].
Historically, B. henselae and B. clarridgeiae have been
frequently isolated from cat blood; however, successful
isolation generally required prolonged incubation
(weeks) in a high CO2 incubator. Using the same isola-
tion approaches, B. koehlerae has been infrequently iso-
lated, despite numerous, worldwide epidemiological
studies designed to determine the prevalence of Barto-
nella spp. bacteremia in cats [9]. Therefore, it appears
that B. koehlerae is more fastidious than B. henselae or
B. clarridgeiae. To date, successful isolation of B. koeh-
lerae from cats and the one human patient has consis-
tently required the use of chocolate agar plates [1,2,7].
In recent years, our research group has focused on the
enhanced diagnostic detection of Bartonella spp. in
healthy and sick animals and in immunocompetent
human patients [10-15]. Initial efforts to enhance the
sensitivity of PCR detection of Bartonella-specific DNA
sequences in patient samples, as a sole molecular diag-
nostic strategy, proved unsatisfactory. Therefore, we
incorporated pre-enrichment culture of aseptically-
obtained diagnostic specimens (blood, cerebrospinal,
aqueous, and joint fluids and effusions) using a liquid
insect cell culture-based medium (Bartonella alpha Pro-
teobacteria Growth Medium, BAPGM) prior to PCR
testing [10-16]. By combining enrichment culture fol-
lowed by PCR amplification, diagnostic sensitivity was
improved substantially over PCR alone, particularly
when testing samples from sick dogs and immunocom-
petent human patients. The use of BAPGM has also
facilitated the documentation of human infections with
two novel Bartonella species [14,15].
In this study, we report the molecular detection of B.
koehlerae DNA prior to or after enrichment culture in
eight patients who were tested because of a spectrum of
poorly defined illnesses. After molecular documentation
of B. koehlerae infection in these patients, a serological
test was developed and serum samples were tested
retrospectively.
Patients and Methods
Blood and serum samples from these individuals were
submitted by an attending physician to the
Intracellular Pathogens Research Laboratory (IPRL) for
attempted isolation or molecular detection of a Barto-
nella species. In most instances, these patients were
tested because of a history of extensive arthropod or
animal contact. Patient samples were tested as a com-
ponent of an IRB approved study entitled: Detection of
Bartonella Species in the Blood of People with Exten-
sive Animal Contact (North Carolina State University
Institutional Review Board, IRB#s 4925-03 and 164-08-
05). None of the patients reported in this study have
been described in previous manuscripts from our
laboratory [10,11,15]. A standardized questionnaire was
completed by each individual and included age, gender,
animal and arthropod exposure, outdoor activity, tra-
vel, clinical symptoms, duration of illness and co-mor-
bid conditions. The duration of illness varied
substantially among individuals, as did prior diagnostic
evaluations and previous treatments.
The authors used a previously described approach
incorporating pre-enrichment culture of blood in Barto-
nella alpha Proteobacteria growth medium (BAPGM)
followed by PCR targeting the 16S-23 S intergenic
spacer (ITS) region and the rpoB gene [10-13,16,17].
Bacterial isolation, PCR amplification, and cloning were
performed using previously described methods
[10,11,13,17]. Sequences were aligned and compared
with GenBank sequences using AlignX software (Vector
NTI Suite 6.0, InforMax, Inc.) [17]. The BAPGM diag-
nostic platform consists of PCR following direct extrac-
tion of DNA from both blood and serum samples, PCR
following enrichment culture for at least 7 days, and
PCR following subculture onto a blood agar plate, if col-
ony growth is visualized. To assess for potential labora-
tory contamination, an un-inoculated BAPGM culture
flask was processed simultaneously and in an identical
manner with each batch of patient blood and serum
samples tested. Specifically, while establishing cultures
using a batch of samples in a biosafety hood, the top
was removed from the BAPGM un-inoculated control
flask until all patient samples had been processed. Fol-
lowing the standard operating procedures in the Intra-
cellular Pathogens Research Laboratory, sample
preparation including BAPGM cultures and agar plate
sub-inoculation, DNA extraction, PCR preparation and
PCR amplification and analysis were performed in sepa-
rate laboratory rooms to avoid culture as well as DNA
contamination. In addition, negative and positive Barto-
nella DNA test control samples, consisting of bacteria-
free blood DNA and DNA spiked with B. henselae geno-
mic DNA at 0.5 genome copies per microliter, respec-
tively, were used for each batch of DNA tested. To
minimize chance contamination with whole bacteria, the
laboratory does not use a BAPGM positive control and
has never used a B. koehlerae PCR positive control. All
Breitschwerdt et al. Parasites & Vectors 2010, 3:76
http://www.parasitesandvectors.com/content/3/1/76
Page 2 of 9
PCR and BAPGM culture negative controls remained
negative throughout the duration of the study.
Bartonella koehlerae, B. vinsonii subsp. berkhoffii, B.
henselae and Rickettsia rickettsii antibodies were deter-
mined following traditional immunofluorescence anti-
body assay (IFA) practices [10,11] with fluorescein
conjugated goat anti-human IgG (Pierce Biotechnology,
Rockford IL). Bartonella vinsonii subsp. berkhoffii geno-
type I (NCSU CO-1-93) and R. rickettsii (NCSU CO-1-
08) originated from isolates made in our laboratory
from natural canine infections. B.koehlerae (NCSU FO-
1-09) and B. henselae H-1 (NCSU FO-93-23) were iso-
lated from natural feline infections. Bartonella organisms
were passed from agar grown cultures into AAE12 or
DH82 cell cultures to obtain antigens as expressed when
organisms are carried intracellularly in host blood. R.
rickettsii cultures are maintained in cell lines due to the
intracellular obligate growth requirements. Heavily
infected cell cultures were spotted onto 30-well Teflon
coated slides (Cel-Line/Thermo Scientific), air dried,
acetone fixed and stored frozen. Serum samples were
diluted in phosphate buffered saline (PBS) solution con-
taining normal goat serum, Tween-20 and powdered
nonfat dry milk to block non-specific antigen binding
sites. All available patient sera were screened at dilutions
of 1:16 to 1:64. All sera that were reactive at 1:64 were
further tested with twofold dilutions out to 1:8192. To
avoid confusion associated with possible non-specific
binding found at low dilutions and to standardize with
other laboratories such as the CDC, a cutoff titer of 1:64
was used to define a seroreactive titer. For preliminary
testing purposes, B. koehlerae seroreactivity was assessed
among six of the eight patients described in this study
and using sera from 30 healthy people with minimal
animal and arthropod exposure. A sufficient volume of
serum was not available for 2 patients.
Results
Between 2005 and 2009 the IPRL performed 430 human
blood cultures using the BAPGM enrichment platform,
of which 8 individuals were found to be infected with B.
koehlerae. There were four males and four females,
ranging in age from 24 to 64 years, all of whom resided
in the eastern United States (Table 1). Four of the eight
individuals in this study were veterinarians, all of whom
had historical animal contact for at least 10 years. Of
the non-veterinarians, patients 1 and 7 reported animal
contact of at least 10 years, patient 7 reported 6 to 10
years of animal contact, whereas patient 5 reported no
recent animal contact. All veterinarians reported bites
or scratches from cats, dogs and less frequently other
animal species. Overall, fatigue, insomnia, joint pain,
headache, memory loss, and muscle pain were the most
frequently reported symptoms (Table 2).
For each patient, 16S-23 S ITS region PCR results
were confirmed by DNA sequencing (Table 3). As the
ITS region varies among Bartonella species and strains,
sequence length ranged from 425 to 670 base pairs.
Subsequently, the B. koehlerae rpoB gene was success-
fully amplified and sequenced (660 bp) from six of eight
patient blood samples. In the context of the BAPGM
platform, B. koehlerae was more often amplified directly
from patient blood or serum samples, whereas the B.
koehlerae PCR was positive only after enrichment cul-
ture for 7 or 14 days in BAPGM for three patients. Only
one patient was PCR positive following both direct
extraction and after enrichment culture. No subculture
isolates were obtained from any patient in this study. To
date, the cat isolate used as a source of IFA antigen in
this study is the only B. koehlerae subculture isolate
obtained in our laboratory after BAPGM enrichment
culture.
By retrospective testing, B. koehlerae antibody titers
ranged from <1:16 to 1:256 in the six patients, for
whom serum was available. Five of these six patients
had titers of 1:64 or greater (Table 3). Bartonella koeh-
lerae antibodies were not detected (titers < 1:16) in the
30 healthy control sera. Three patients had a 1:64 IFA
titer to B. vinsonii subsp. berkhoffii and DNA of this
subspecies was sequenced from these 3 patients,
whereas one patient was PCR positive for B. vinsonii
subsp. berkhoffii and B. henselae at different testing time
points, but was not seroreactive to B. henselae. Due to
the history of repeated seroreactivity to Rickettsia
Table 1 Age, gender, state of residence and duration of illness in eight patients infected with Bartonella koehlerae.
Patient # Age Gender Occupation State of Residence Duration of Illness
1 24 F Manager, Retail Store Pennsylvania 6 Months
2 59 F Veterinarian New Hampshire 6 Years
3 61 M Veterinarian, Farmer Florida 2 Years
4 41 F Veterinarian Virginia 18 Years
5 64 F Homemaker Maryland 9 Months
6 27 M Artist Maryland 2 Years
7 48 M Landscape Architect North Carolina 2 Months
8 33 M Veterinarian North Carolina 2 Months
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rickettsii antigens in patient 7, all patient sera were
tested for potential cross reactivity to Rickettsia anti-
gens. IFA titers to R. rickettsii ranging from 1:64 to1:128
were found in two patients (#2 and #7) (Table 3).
A brief medical history for each patient follows:
Patient 1 was examined by a rheumatologist in Octo-
ber 2008 due to recent onset of fatigue, headache,
insomnia and bilateral hip pain. This patient reported
daily contact with dogs, no direct contact with other
animal species and minimal to no exposure to arthro-
pods. Bartonella vinsonii subsp. berkhoffii was amplified
and sequenced after direct extraction from a blood sam-
ple; however, growth was not obtained by BAPGM
enrichment culture. She was not seroreactive to B. vin-
sonii subsp. berkhoffii or B. henselae antigens, but was
retrospectively found to be seroreactive to B. koehlerae
antigens (Table 3). Treatment with minocycline was
accompanied by more frequent headaches and increased
hip pain. She then received azithromycin with some
decrease in headache frequency, but no change in hip
pain. Following antibiotic administration, she was no
longer B. koehlerae seroreactive; however, in February
2009, due to persistent fatigue, headache, hip joint and
muscle pain, and newly acquired numbness and tingling
sensations in the feet and hands, the patient was
retested in the IPRL. B. koehlerae was amplified follow-
ing direct extraction from blood, but bacterial DNA was
not amplified from the enrichment or subcultures.
Shortly after adding rifampin to the azithromycin in
March 2009 she experienced a Jarisch-Herxheimer-like
reaction with acutely worsening symptoms; however,
after continuation of both antibiotics there was gradual
improvement in energy level, decreased hip pain and
less frequent headaches during the subsequent 2
months. In November 2009, two months after complet-
ing antibiotics, the woman reported decreased amplitude
and frequency of hip pain.
Patient 2, a veterinarian with extensive companion
animal contact, reported an eight-year history of illness,
which was primarily characterized by muscle pain.
Fibromyalgia was diagnosed in March 2003. After B.
koehlerae was amplified and sequenced from a BAPGM
enrichment culture in March 2009, the woman was trea-
ted with a 10-week course of rifampin and levofloxacin.
Forty eight hours after starting antibiotics, she experi-
enced a Jarisch-Herxheimer-like reaction, after which
there was gradual, but definite clinical improvement,
characterized by decreased stiffness and muscle pain,
particularly in the morning and after exercise. Eight
weeks after completing the course of antibiotics the
patient reported resolution of muscle pain and metatar-
sophalangeal joint pain, which was reportedly swollen
for ten years.
Patient 3, also a veterinarian, was chronically ill for 2
years. He had extensive contact with a spectrum of pet
and production animals, also frequently participated in
outdoor activities, including farming, hiking and hunting
and had daily to weekly exposure to fleas, ticks, biting
flies, and mosquitoes. His initial symptoms were most
consistent with a severe, protracted flu-like illness,
accompanied by fatigue and headaches. Afterwards, he
developed numerous other symptoms which would wax
and wane in severity, including shooting pain originating
at the base of the skull and radiating over the head
(Table 2). The most serious symptom described by this
patient was frequent to near constant coughing resulting
in production of large quantities of green sputum that
induced choking and difficulty breathing. Based upon
allergy test results, the patient was hyposensitized for
nearly one year, without symptomatic improvement.
Chronic obstructive pulmonary disease (COPD) was
diagnosed, but no microbiological testing was per-
formed. Approximately 6 months after development of
bronchial signs the man developed sinusitis, which in
March 2008 required surgical drainage. The respiratory
illness had become so debilitating that continuing to
work was a daily challenge and eventually the man
avoided meetings and social gatherings due to the dis-
ruptive nature of his cough. B. koehlerae DNA was
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amplified and sequenced following direct extraction
from two blood samples obtained five weeks apart and
for a third time from the initial BAPGM enrichment
culture. After a 3-month course of doxycycline and
rifampin, he experienced an increased energy level
accompanied by substantial overall symptomatic
improvement including resolution of the sinusitis, a
nearly complete elimination of the cough and a notable
decrease in right stifle joint crepitus, which he had
previously attributed to old age. There was no relapse in
symptoms during the eight month follow-up period.
Patient 4 developed retro-ocular headaches and pain
in the elbow and shoulder in 1991, at the time of gra-
duation from veterinary school. Within a year, pain also
involved the hip joints and knees. Due to subsequent
involvement of peripheral joints, accompanied by
increasingly severe fatigue, the patient was cared for by
a rheumatologist and various other medical specialists.
Table 3 Serological and PCR results for eight patients infected with Bartonella koehlerae.
Patient Date IFA Reciprocal Titers PCR Results
B. koehlerae B. henselae Bvb II R. rickettsii ITS PCR rpoB PCR
10-2008 64 <16 <16 <16 Bvb*,a Neg
1 02-2009** <16 <16 <16 <16 B. koehleraea B.koehleraea
1 04-2009** <16 <16 <16 <16 Bsppb Neg
2 03-2009 <16 <16 32 64 B. koehleraec B.koehleraea
2 04-2009 NA NA NA NA Neg Neg
2 07-2009** <16 <16 <16 16 B. koehleraea Neg
2 10-2009** <16 <16 <16 <16 Neg Neg
3 03-2009 64 <16 64 <16 B. koehleraea B.koehleraea
3 04-2009 NA NA NA NA B. koehleraec Neg
3 05-2009** 64 <16 32 <16 Neg Bvb*,a
3 08-2009** 256 <16 16 <16 Neg Neg
3 09-2009** <16 <16 <16 <16 Neg Neg
4 4-13-2009 <16 <16 <16 32 B. koehleraeb Neg
4 4-30-2009** <16 <16 <16 <16 Neg Bvb*,a
4 6-02-2009** <16 <16 32 <16 Neg Neg
4 6-09-2009** <16 <16 64 16 Neg Neg
4 6-30-2009** 64 <16 64 <16 Neg Neg
5 05-2009 NA NA NA NA B. koehleraea B.koehleraea
6 05-2009 NA NA NA NA B. koehleraea B.koehleraea
7 04-2009 64 <16 32 128 B. koehleraeb Neg
7 06-2009 64 <16 64 64 Neg Bvb*,a
7 07-2009 64 <16 <16 64 B. henselaea Neg
7 11-2009** 256 <16 <16 16 B. henselaea Neg
8 04-2009 64 <16 <16 16 B. koehleraeb Neg
8 05-2009 64 <16 <16 <16 B. koehleraea B.koehleraea
8 07-2009 64 <16 <16 32 Neg Neg
8 08-2009 <16 <16 32 <16 Neg Neg
All ITS and rpoB PCR amplicons were sequenced to confirm genus and species identity.
*Bvb = Bartonella vinsonii subsp. berkhoffii genotype II
Bspp = amplicon generated with 16S-23 S ITS primers, but unable to obtain a DNA sequence.
** Denotes post-antibiotic testing. NA = Sample not available.
a = amplicon sequenced from blood or serum
b = amplicon sequenced from BAPGM enrichment blood culture
c = amplicons sequenced from both blood and BAPGM enrichment blood culture
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Beginning in 2001, she developed a peripheral neuropa-
thy. B. koehlerae DNA was amplified and sequenced
from the initial BAPGM enrichment blood culture
whereas B. vinsonii subsp. berkhoffii was amplified and
sequenced directly from a post-treatment blood sample,
obtained one month later. B. koehlerae DNA was con-
currently amplified and sequenced from one of her pet
cats. Following administration of doxycycline, Bartonella
spp. DNA was not amplified from three subsequent
blood culture attempts, but there was minimal change
in symptoms. Beginning in August 2009, azithromycin
and minocycline were prescribed for three months, dur-
ing which time symptomatic improvement was reported.
In March, 2010, the patient reported resolution in joint
and muscle pain, peripheral neuropathy, neurocognitive
abnormalities and proprioceptive deficits.
Patient 5 had a history of gastroparesis, paroxysmal
atrial fibrillation and flutter that developed in December
2008 (status post ablation therapy), and a 2 year history
of bilateral symmetric tingling in the first 3 toes of both
feet with no loss of sensation, similar but milder neuro-
pathy in her hands, and cognitive impairment, which
she described as ‘brain fog’. She had been treated medi-
cally for atrial fibrillation and osteoporosis. She reported
minimal to no exposure to biting insects, no recent con-
tact with animals, but had previously owned a dog. The
patient had numerous small varicosities on the lower
extremities, lower extremity bursitis; and tenderness in
the right lateral quadriceps area. B. koehlerae was ampli-
fied directly from the blood sample but the BAPGM
enrichment culture and subcultures were negative.
Serum was not available for serological testing. In June
2009, azithromycin was administered for B. koehlerae
infection. By July 2009 the woman reported improved
cognition and short term memory, and increased energy.
During the next 3 months, azithromycin was continued
and the patient experienced increased symptoms of GI
dysmotility, intermittent flu-like symptoms accompanied
by intense chills without rigors and constant symmetric
tingling of first 3 toes. Despite these symptoms, the
“brain fog” and tingling in the hands were much
improved, there was some improvement of neuropathy
on left side, but the integrity of her short term memory
fluctuated.
Patient 6 was diagnosed with idiopathic multi-focal
retinitis by an ophthalmologist in August, 2008, which
responded to high dose prednisone (60 mg/day). The
patient subsequently developed cardiac arrhythmias,
characterized by extrasystoles and pauses, skeletal mus-
cle twitching and spasms, and fatigue in November
2008. A fluorescence angiogram again documented ret-
inal inflammation and prednisone therapy was re-insti-
tuted. In June 2009, the patient reported partial overall
improvement in symptoms while taking prednisone. A
rheumatoid factor assay was positive (21, reference
range 0-14). A vasculopathy, with accompanying retino-
pathy, was diagnosed.
There was no history of tick bites, but the patient had
rescued three feral cats, which he maintained as pets
and had experienced cat scratches and bites. B. koeh-
lerae was amplified directly from the blood sample, but
the BAPGM enrichment culture and subculture were
negative. The patient was treated with azithromycin and
minocycline. When examined in December 2009, he
reported overall symptomatic improvement, despite hav-
ing not completed the entire course of antibiotics.
Treatment with azithromycin and rifamipin for the next
six months resulted in alleviation of symptoms, includ-
ing no recurrence of visual floaters and light flashes.
Patient 7, who had daily dog contact and participated
frequently in outdoor activities, reported recent onset of
severe fatigue, difficulty remembering and joint pain and
a history of tick exposure. During the past few years the
patient developed a dietary allergy to beef and pork and
fatigue, aches, “fogginess” that he had attributed to the
aging process. Antibodies to Rickettsia rickettsii were
previously detected by a commercial laboratory and
antibodies were also detectable in the IPRL in three
serum samples obtained at monthly intervals. This indi-
vidual was consistently seroreactive to B. koehlerae anti-
gens, intermittently seroreactive to B. vinsonii subsp.
berkhoffii, but was never found to be seroreactive to B.
henselae (Table 3). Bartonella koehlerae, B. henselae or
B. vinsonii subsp. berkhoffii were amplified directly from
four blood samples obtained over a seven-month time
period. After a three-month course of doxycycline and
rifampin, B. henselae DNA was again sequenced from
an extracted blood sample in November 2009 and the B.
koehlerae titer had increased from 1:64 to 1:256. During
the months following antibiotic administration the
patient reported gradual improvement in symptoms and
by February 2010 he described a significant improve-
ment in the “fogginess” and improved ability to remem-
ber and decreased joint pain.
Patient 8 The blood culture from Patient 8 was
obtained due to the acute onset of ventricular tachyar-
rhythmia’s that developed three weeks after coccygody-
nia surgery and during a professionally stressful period
in this individual’s life. Concurrently, this patient
reported difficulty breathing, palpitations and anxiety.
Other medical problems reported during the previous
four years, included bilateral knee pain with patellar
chondromalacia, documented by MRI, bilateral carpal
tunnel syndrome and tinnitus involving the left ear.
Although a veterinarian, with extensive prior animal
contact, this individual had minimal occupational expo-
sure during the 4-year period prior to PCR detection of
B. koehlerae in the initial BAPGM enrichment blood
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culture. A blood sample obtained one month later also
contained B. koehlerae DNA. As two subsequent blood
cultures were B. koehlerae negative and because the
patient was no longer B. koehlerae seroreactive, this
individual elected to not be treated with antibiotics.
Discussion
Although biased by a study population consisting of
individuals with extensive arthropod and animal expo-
sure, the results of this study suggest that B. koehlerae
bacteremia occurs more frequently (8 of 430 patients
tested, 1.8%) in immunocompetent patients than pre-
viously suspected. Also, as the duration of illness in
these patients ranged from two months to eighteen
years, B. koehlerae may induce a chronic intravascular
infection, as recently proposed for B. vinsonii subsp. ber-
khoffii and B. henselae [18]. In addition, repeated ampli-
fication of B. koehlerae DNA from sequentially obtained
blood samples from patients 2, 3, and 8 further supports
the possibility of a persistent or relapsing pattern of bac-
teremia. Similar to two previous studies [10,11], the
mean age of this patient cohort was 45 years. The most
frequent symptoms reported by these patients included
fatigue, insomnia, joint pain, headache, memory loss,
and muscle pain. Although non-specific, these symp-
toms are very similar to those previously reported in
bacteremic patients that were infected with B. henselae,
B. vinsonii subsp. berkhoffii, Candidatus B. melophagi or
individuals co-infected with more than one Bartonella
spp. [10,11,15]. Because recent studies describe very
similar patterns of illness in immunocompetent patients
[10,11,15], prospective controlled studies are needed to
critically assess whether there is an association between
chronic intravascular infection with Bartonella spp. and
specific disease entities. Importantly, sequential studies
involving veterinarians and veterinary technicians, in
conjunction with appropriate control groups, might
allow for more rapid determination of the pathogenic
potential of a growing number of zoonotic Bartonella
spp. in immunocompetent individuals.
Our findings do not confirm that B. koehlerae was a
cause or co-factor in the illnesses described in these
patients or that the response to therapy was related to
elimination of this bacteria. However, despite protracted
medical histories, all seven patients treated with antibio-
tics reported substantial symptomatic improvement and
in most instances B. koehlerae antibodies and DNA
were no longer detected in post-treatment samples. Fail-
ure to consistently detect B. koehlerae bacteremia by
repeat testing in patients 2 and 7 prior to antibiotic
administration or in patient 8 who was never treated
with antibiotics could relate to a relapsing pattern of
bacteremia, as demonstrated following experimental
inoculation of B. henselae and B. clarridgeiae into cats
[19]. Alternative explanations include limited sensitivity
of the BAPGM platform for the detection of B. koeh-
lerae, or immunological clearance of these bacteria from
the vasculature. Although co-infection with more than
one Bartonella sp. has been reported with increasing
frequency in human patients [10,11,18,20], the detection
of B. vinsonii subsp. berkhoffii DNA in four of eight
patients infected with B. koehlerae was an unexpected
finding. Cats are considered the primary reservoir hosts
for B. koehlerae, whereas dogs and wild canines are the
primary reservoir hosts for B. vinsonii subsp. berkhoffii.
Infection with B. vinsonii subsp. berkhoffii spanning an
eighteen month time frame occurred in a cat with
recurrent osteomyelitis [21]. Although the mode of B.
vinsonii subsp. berkhoffii transmission could not be
determined, patients 3 and 4 were companion animal
veterinarians, who had frequent contact with both cats
and dogs; whereas, patients 1 and 7 reported primarily
dog contact.
When attempting to establish if a patient has been
previously exposed to or is actively infected with B.
koehlerae, serology, direct PCR from blood and serum
and enrichment culture should be examined. Although
IFA results reported in this study should be considered
preliminary, five of six patients for whom serology was
performed were B. koehlerae IFA seroreactive at titers of
1:64 to 1:256, whereas B. koehlerae antibodies were not
detected in thirty healthy individuals. There was no ser-
ological crossreactivity to B. henselae antigens in these
B. koehlerae infected patients. As reported for other B.
henselae infected individuals [10,11], patient 7 was never
B. henselae seroreactive, despite sequencing B. henselae
DNA at two temporally separated sample testing time
points. In contrast to high antibody titers and serologi-
cal crossreactivity reported in patients with Bartonella
sp. endocarditis, these bacteremic patients had low anti-
body titers and minimal crossreactivity. Previous studies
have suggested the possibility of serological cross reac-
tivity between Bartonella and Rickettsia spp. antigens
[22]. Patients 2 and 7 had R. rickettsii antibody titers
ranging from 1:64 to 1:128, whereas patients 4 and 8
had very low titers (1:16 and 1:32 at different time
points). There was no consistent pattern of cross reac-
tivity among Bartonella and Rickettsia antigens in this
study, therefore prior exposure to a Rickettsia sp. seems
more likely than crossreactivity among Rickettsia and
Bartonella sp. antigens. When specific pathogen free
dogs were infected with B. vinsonii subsp. berkhoffii gen-
otype I, there was no cross reactivity to R. rickettsii anti-
gens by IFA testing [23].
The medical history of patient 3, an older veterinarian,
was unique in the context of severe, chronic bronchitis
and sinusitis. The pulmonary disease was of such a
severity that the man could only marginally function in
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routine work related activities. Atypical manifestations
and more severe clinical presentations have been pro-
posed to occur in older individuals infected with Barto-
nella spp. [24]. Although considered infrequent,
pulmonary manifestations have been associated with B.
henselae infections in patients with CSD [25]. In addi-
tion, B. henselae DNA was amplified and sequenced
from nodular granulomatous pulmonary nodules that
developed in a renal transplant recipient, who had
extensive cat contact [26].
Patient 4 developed a peripheral neuropathy after a
ten-year history of joint pain, whereas patients 1 and 6
reported tingling sensations in the hands or feet, which
could be indicative of a sensory neuropathy. A distal
axonal sensomotor polyneuropathy, vasculitis and Ray-
naud’s phenomenon were reported in a 40 year-old man
with a five year history of recurrent, painful toe ulcers
[27]. Diagnosis of bartonellosis in that patient was sup-
ported by a B. henselae antibody titer of 1:1,024 and
remission of the vasculitis and the polyneuropathy fol-
lowing treatment with erythromycin for three months
followed by doxycycline for three weeks. Biopsy of the
patient’s sural nerve demonstrated an axonal neuropathy
with a neurogenic muscular atrophy. The authors con-
cluded that B. henselae infection should be considered
in patients with vasculitis and polyneuropathic syn-
dromes. It is also possible that B. koehlerae should also
be among the differential diagnoses for patients with
peripheral neuropathy.
Interestingly, three patients in this study reported
atrial or ventricular tachyarrhythmias. Although an
increasingly well recognized cause of endocarditis, the
potential role of Bartonella spp. as a cause of myocardi-
tis or arrhythmias has been incompletely studied [28].
Bartonella henselae has been implicated on the basis of
molecular pathology as a cause of sudden death in
Swedish orienteers [29]. In a more recent study from
Switzerland, arrhythmogenic right ventricular cardio-
myopathy (ARVC), an important cause of sudden death
in young adults, was serologically associated with B.
henselae antibodies [30]. These authors concluded that
further studies in larger patient cohorts seem justified to
investigate a possible causal link between chronic B.
henselae and ARVC, in particular the sporadic (nonfa-
milial) form of the disease. Chronic active myocarditis
requiring heart transplantation was also reported in a
previously healthy young man after developing B. hense-
lae-induced cat scratch disease [31]. In the context of
intravascular pathogens, Bartonella species may prove to
be unique, as these bacteria can induce intraerythrocytic
infection, vascular endothelial infection and experimen-
tally can achieve intracellular localization within mono-
cytes, macrophages, dendritic cells and CD 34+
progenitor cells [32,33]. Assuming persistent infection
coupled with a highly adapted ability to evade immune
recognition by the host, these highly fastidious intravas-
cular and intracellular bacteria could contribute to a
spectrum of disease pathology over a protracted period
of time [32].
On a daily basis, veterinarians are repeatedly exposed
to a spectrum of animal species and to their associated
arthropods. Unfortunately, due to the unknown duration
of B. koehlerae infection in an immunocompetent per-
son, the potential for repeated exposures over time and
technical limitations associated with the molecular doc-
umentation of co-infection, the source and the timing of
Bartonella infection in these individuals could not be
accurately determined. Although veterinary professionals
appear to be at a high risk of occupational exposure for
Bartonella spp., numerous people in society have fre-
quent or episodic exposure to animals and arthropod
vectors. Increased attention to modes of transmission
and risk factors for Bartonella spp. infections is war-
ranted [34].
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